Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIO-B

$374.77

Updated: 24/09/2026, 11:39:11

Market Cap
$10.25B
Sector
Healthcare
Industry
Medical - Devices
Country
US
Stock valuation chart
One-year closing share-price history for BIO-B
Company Profile

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.

USD
NYSE
CEO: Norman D. Schwartz
Employees: 7,450
https://www.bio-rad.com
Asset Summaries
Latest generated summaries for BIO-B

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for BIO-B.
Share price
$374.77
Market cap
$10.25B
Exchange
NYSE
Currency
USD
CEO
Norman D. Schwartz
Employees
7,450
IPO date
21/09/1999
Beta
1.112
Last dividend
$0.00
Day range
$374.77 – $385.78
52-week range
$244.54 – $387.10
1-day performance
2.65%
1-year performance
53.26%
Current drawdown (1Y)
-3.19%
CIK
0000012208
CUSIP
090572108
ISIN
US0905721082
Created
07/12/2025, 03:00:01
Last update
24/09/2026, 11:39:11

Track Bio-Rad Laboratories, Inc. with an AI analyst

See which prediction-market events move BIO-B, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to BIO-B from your Railway `news_articles` table.

No news found for this symbol.